A new report examines whether Iowa farmers, highly exposed to pesticides, are getting cancer more often than others in the ...
Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...
A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry high-risk cancer variants.
4don MSN
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...
Treating ovarian cancer remains a race against time. In Italy, eight out of ten women receive a late diagnosis, often when the disease is already at an advanced stage. To provide concrete ...
Ovarian cancer (OC) is a "silent killer" with an annual incidence of 11.2 per 100,000 and mortality of 7.6 per 100,000. Most cases are diagnosed at ...
Caris AI Insights are proprietary and only available to Caris Life Sciences customers. IRVING, Texas, /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leadin ...
Among women using medically assisted reproduction (MAR), the overall incidence of cancer was comparable to that of the general population, according to a study published online March 10 in JAMA ...
A teacher said she is "facing a death sentence" after battling a form of cancer known as the silent killer. Emma Durkin was ...
Our result shows the detection of SVs from pre-treatment cfDNA using tumor-informed breakpoints-spanning ddPCR is feasible and may enable a novel and ...
Partnerships between universities and industry are a major driver of medical innovation, with ASX-listed healthcare companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results